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Abstract 
 
Background: Placental morphology and cellular arrangement can be altered in maternal diseases. Rheumatic heart 
disease (RHD) is a chronic heart condition that can lead to death in pregnant women. The aim of this study is to 
determine the histological changes of the placenta in pregnant women suffering from RHD. Methods: Placentae were 
collected from 10 healthy pregnant women, and 31 pregnant women with heart conditions (26 with RHD and 5 with 
NRHD) who had been admitted to the Baghdad Teaching Hospital. Placental tissues were fixed in 10% formal-saline 
and were processed for light microscopy. Measurements including the placental weight and diameter of the chorionic 
villi capillaries were recorded. Results: The results indicate that there are many histological changes in pregnant 
women with RHD such as hyalinisation, fibrosis of the chorionic villi, proliferation of trophoblastic cells, and 
thickening of its membrane. Additionally, expectant mothers with RHD experience a reduction in capillary diameter 
and thickening of the capillary walls, and decreased size and weight of their placenta when compared with the control. 
Conclusions: Heart diseases, especially RHD, are associated with developmental damage of the placenta in pregnant 
women by injuring the endothelial cells of the placentas capillaries. 
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Introduction 
 
The placenta is a short-lived organ interposed between 
the mother and foetus, and it is essential for the growth 
and survival of the foetus in the uterus.1 The placenta 
develops in the uterus during pregnancy and is composed 
of two different surfaces; the maternal surface and the 
fetal surface. The placentas anatomical and functional 
features come from both the mother and foetus and it 
functions as an endocrine organ, a barrier, and a transporter 
of substances between the maternal and fetal circulation.2,3 
There is increasing evidence that pathophysiological 
changes in maternal homeostasis may modify placental 
structure and function, thus influencing the fetal growth 
rate and causing potential complicatations.4,5 The 
architecture of the placenta can be altered in many 
maternal diseases such as diabetes mellitus, hypertension, 
pre-eclampsia, eclampsia, etc.6 
 
Maternal cardiac disease complicates 1% to 3% of all 
pregnancies and is responsible for 10% to 15% of maternal 
mortality.7 Rheumatic heart disease (RHD) describes a group 
of heart disorders that occur as a result of rheumatic fever.8 
Epidemiologic studies show that RHD is the most common 
cause of valvular disease in industrialised countries such 
as the USA, Germany, and the UK.9-11 It is a current 
public health concern around the world, with 90% of all 
heart disorders found in women of childbearing age 
being rheumatic in origin, in developing countries. 
However, an accurate estimation of trends of rheumatic 
fever in these countries is not possible due to an absence 
of reliable health statistics.9 RHD is a major cardiac 
concern in pregnant woman and affected individuals are 
susceptible to higher maternal and neonatal mortality 
rates, as found in studies in Eritrea, India, and Iran.12-15 
Mitral stenosis (MS) is the most common manifestation 
of RHD. Damaged valves may result in heart failure and 
abnormal valves can increase the risk a trial fibrillation 
and valvularinfections.8 MS remains the most common 
acquired valvular lesion in pregnant women and the 
most common cause of maternal death due to cardiac 
complications.16 
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Examination of the placenta is important to understand 
the pathophysiology of maternal and fetal diseases. Many 
disorders found in pregnant woman are accompanied by 
pathological changes in the placenta and are associated 
with high perinatal morbidity and mortality.6,17 The purpose 
of this study is to investigate the histopathological changes 
that occur in the placenta of pregnant women with RHD. 
 
Methods 
 
41 placentas were collected at the Department of Obstetrics 
and Gynaecology, Baghdad Teaching Hospital in Baghdad 
City. 10 placentas were collected as a control group, from 
healthy pregnant woman with no associated diseases, 
who were aged between 19 and 35. 31 placentas were 
collected from pregnant women, aged between 20 and 
39 years, with a provisional diagnosis of heart disease. 
Of these 31 patients, 26 had a diagnosis of RHD and 5 
were patients with non-rheumatic heart disease (NRHD). 
This research project was conducted in compliance with 
the humane care standards outlined in the National 
Institute of Health Guide for Care, with the ethic approval 
from the Al-Mustansiriah University. 
 
Placentae were collected immediately after delivery, and 
were washed to remove any clotted blood. The placental 
weights were recorded and tissue samples from the 
maternal portion were fixed in a 10% formal-saline 
solution for 8 hours. They were then dehydrated using a 
series of ethanol products, cleared using two changes of 
xylene, impregnated, and embedded in paraffin wax. 
Paraffin sections of 5 µm thick were stained with 
Haematoxylin and Eosin and periodic acid-Schiff. The 
diameters of the chorionic villi capillaries were measured 
using ocular micrometre. 
 
Results were analysed using standard methods to 
determine the mean and standard error of the mean. In 
addition, one-way analysis of variance was used to test 
the significant differences between the study sample and 
the control group. p values less than 0.05 were considered 
to be significant. 
 
Results 
 
Placental weight. Results showed no significant difference 
(p ≥ 0.05) in the mean values of placental weight of 
patients with RHD (516.23 ± 24.94) and NRHD (522.86 
± 23.35) when compared with the subjects in the control 
group (624.00 ± 73.12) (Table 1). 
 
Capillary diameter. There were no significant reductions 
in the capillary diameter of the placentae of patients 
with RHD (0.973 ± 0.015) and NRHD (0.944 ± 0.023) 
when compared with the control group (1.008 ± 0.027) 
(Table 2). 
 
Histological observation. Light microscopy examination 
of the placenta of the control group showed normal 
structural features. The bulk of the chorionic villi consisted 
of connective tissue containing fetal capillaries, bundles 
of collagen fibres, and a variety of connective tissue 
cells mostly fibroblasts and macrophages. The villi are 
surrounded by syncytiotrophoblasts which stain dark blue, 
and are separated by inter-villous spaces that contain 
maternal blood cells and clumps of fibrinoid (Figure 
1A). 
 
Histological investigation of the placentae collected 
from the patients with heart disease showed multiple 
degenerative changes. There was an increased incidence 
of hyalinisation and fibroid necrosis of the villi, and 
crowded and degenerating villi with decreased inter-
villous spaces and fibrin deposition. Additionally, there 
were numerous arteriosclerotic and congested blood 
vessels with endothelial degeneration of the endothelial 
cells, thickened walls of fetal blood capillaries with 
associated progressive fibrosis, degeneration of tropho-
blastic cells, and haemorrhage in the inter-villous spaces 
(Figure 1 B, C, D and Figure 2). 
 
 
 
Table 1.  The Mean Values of Placental Weight (gm), of 
Control, RHD and NRHD Pregnant Women 
 
Group No. Mean(gm) ± S.E.M. 
RHD 26    516.23 ± 24.94* 
NRHD 5              522.86 ± 23.35* 
Control  10             624.00 ± 73.12  
 
Data are presented as mean ± SEM. *: None significantly (p ≥ 0.05) 
different from their control 
 
 
 
Table 2.  Capillaries Diameter (µm) in RHD, NRHD and 
Control Pregnant Women 
 
Group No. Mean(µm) ± S.E.M. 
RHD 26    0.973 ± 0.015* 
NRHD 5    0.944 ± 0.023* 
Control 10  1.008 ± 0.027 
 
Data are presented as mean ± SEM. *: None significantly (p ≥ 0.05) 
different from their control 
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Figure 1.  Photomicrograph of sections from human placentae of: (A) A control group showing normal architecture structure 
with normal trophoblast “arrow”; (B, C, D) Patients with RHD (mitral stenosis) showing degenerating villi with 
thickened fetal congested blood capillaries (C0), marked fibrosis (F), and exfoliated trophoblast cells (dark spots). 
A, B and C, “H&E”; D “trichrome”, x 200 
 
 
 
 
Figure 2.  Photomicrograph of sections from human placentae of: (A) Patient suffering from Patent Ductus Arteriosus 
(PDA); (B) A case of mitral regurgitation showing degenerating villi with thickened fetal congested blood 
capillaries (C0), marked fibrosis (F), hyalinization (H) and exfoliated trophoblast cells (dark spots). A, 
“trichrome”; B, “PAS” x 200 
 
 
Discussion 
 
The placenta is a vital organ that connects the developing 
foetus to the maternal uterine wall. It plays a critical 
role during pregnancy including permitting nutrient 
entry, waste removal, and respiratory gas exchange via 
the mother's blood supply. The placenta also fights 
against internal infection, synthesises and releases 
various hormones, and facilitates maternal metabolic 
adaptation to the different stages of pregnancy.18 The 
quality and quantity of maternal blood transported to the 
intervillous spaces of the placenta controls the 
development of foetus.19 The human placenta is a highly 
vascular organ that acts as the fetal lung, and the 
amount of blood flow through the placenta is moderated 
by its vascular arrangement.20 
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Previous studies have demonstrated the morphological 
and histological changes of the placenta in mothers with 
cardiac disease. These changes include a decrease in the 
absolute volume of the placental parenchyma, placental 
weight, thickness, diameter, and surface area. Additionally, 
thickened walls of fetal blood capillaries, crowded 
degenerating villi with decreased intervillous spaces, 
and intravillous and perivillous fibrinoid deposition has 
also been reported.4 Numerous syncytial knots and 
exfoliated trophoblast cells were also observed and a 
thickened layer of subchorionic fibrinoid in the placenta 
of pre-eclamptic mothers.6,21 The presence of infarction, 
retroplacental haematomas, calcification, and a significant 
decrease in the diameter of blood vessels and placental 
diameter has been noted in the placenta of hypertensive 
mothers.17,22 
 
In this study a placental morphometrical analysis was 
completed and the placentas in the RHD and NRHD 
group had lower mean placental weights than those in 
the control group. A previous study found that placental 
weight in pre-eclamptic mothers in India is directly 
proportional to neonatal birth weight.6 Furthermore, 
another study of Indian women with pre-eclampsia found 
that decreased placental weight, thickness, and diameter 
of villi and vessels are related to the pathogenesis of 
maternal and fetal morbidity and mortality.22 A similar 
study of pre-eclamptic Bangladeshi mothers found that 
a decrease in the weight and volume of the placenta was 
related to a substantial decrement of parenchymal tissue 
due to a significant reduction in peripheral villous tissue 
mass, fetal capillary, and intervillous space volume by 
approximately 50% in the placenta.4 Conversely, the 
placenta of diabetic pregnant women in India weighed 
more, and experienced associated syncytial knots, fibrinoid 
necrosis, villous oedema, villous fibrosis, and capillary 
proliferation when compared with normal pregnancies.23 
Diabetes mellitus also induces oedematous stroma, an 
apparent increase in the number of syncytial knots, and 
perivillous fibrin deposition in the villous tissues was 
found in gestational diabetes mellitus placentas.18 
 
Results from this study found a reduction in capillary 
diameter and increased wall thickness of fetal blood 
capillaries in the placentae of RHD and NRHD patients. 
This finding is consistent with the thickened walls of 
fetal blood capillaries, increased density of collagen 
fibres around fetal blood capillaries, and the decrement 
of their lumen associated with decreased fetal blood 
capillaries found in the placentae of pre-eclamptic mothers.21 
A significant decrease in the diameter of blood vessels 
was observed in the placentae of hypertensive mothers, 
leading to a complete lack of capillaries in the terminal 
villi in most areas of the placenta, with subsequent 
formation of a vascular villitis.22 The structural and 
functional changes in the villous capillaries of the 
placenta, such as hypoxia and epigenetic influences, can 
interrupt embryo development.24 Additionally, increasing 
numbers of villous capillaries and thickening of their 
walls has been observed in the placentae of diabetic 
mothers and is considered to be a sign of chronic 
hypoxic changes.25 
 
Results from this histological study have demonstrated 
clear placental changes in pregnant women who suffer 
from heart diseases. Examination of RHD and NRHD 
placentae revealed ruptured villi with congested and 
thickened walls of fetal blood capillaries, degeneration of 
the chorionic villi with diminished intervillous spaces, and 
associated extravasation of fetal RBCs into the maternal 
space. The degeneration of the villi and subsequent 
haemorrhage into the intervillous spaces with intravillous 
fibrinoid deposition correlate with previous findings in 
pregnant women with pre-eclampsia, toxaemia and 
eclampsia.3 These changes are thought to impair blood 
flow in the intervillous spaces and lead to placental 
hypoxia, infarction, and retarded fetal growth.21,26 The 
increased vasculosyncytial membrane thickness and 
decreased area of exchange, as a result of fetal hypoxia, 
can subject the foetus to extensive risks.27 It was found 
that extensive infarction, in cases of toxaemia, were 
associated with low birth weight, placental weight, and 
increased fetal death.27 
 
Previous electron microscopic studies have related the 
pathological changes of placental tissue in pre-eclampsia 
to the changes in endothelial cells, reduced perfusion by 
maternal blood, or to the mitochondrial damage that leads 
to trophoblast apoptosis in pre-eclampsia.28-30 Further 
electron microscopic studies are needed to elucidate 
ultrastructural changes in the placenta of pregnant mothers 
with RHD.  
 
Conclusions 
 
Heart diseases, especially RHD, are associated with 
developmental damage of the placentae in pregnant 
women by injuring the endothelial cells in the placentas 
capillaries. 
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